Wall Street Analysts See a 26.14% Upside in Surgery Partners (SGRY): Can the Stock Really Move This High?

Wall Street analysts’ average price target implies 26.1% upside for Surgery Partners (SGRY). The article notes that while price targets can be unreliable, improving earnings estimate revisions may support further upside. Overall, the piece is constructive but remains an analyst-driven commentary rather than a new company-specific catalyst.

Analysis

Wall Street analysts’ average price target implies 26.1% upside for Surgery Partners (SGRY). The article notes that while price targets can be unreliable, improving earnings estimate revisions may support further upside. Overall, the piece is constructive but remains an analyst-driven commentary rather than a new company-specific catalyst.